Abiraterone, a steroidal cytochrome P 450 17a-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.Form:White SolidMelting Point:223-226°CSolubility:Chloroform (Very Slightly), DMSO (Slightly), Methanol (Slightly)
产品形式
该产品为白色固体。
保存建议
接收到Abiraterone discontinued. See 258687产品后,置于4°C温度下保存。